Claims for Patent: 7,667,114

Summary for Patent: 7,667,114

Title:	Starch branching enzyme
Abstract:	This invention relates to a new starch branching enzyme, and to the gene encoding the enzyme. In particular, the invention provides a new starch branching enzyme type II from wheat, the nucleic acid encoding the enzyme, and constructs comprising the nucleic acid. The invention also relates to a novel method for identification of branching enzyme type II proteins, which is useful for screening wheat germplasm for null or altered alleles of wheat branching enzyme IIb. The novel gene, protein and methods of the invention are useful in production of plants which produce grain with novel properties for food and industrial applications, for example wheat grain containing high amylose or low amylopectin starch.
Inventor(s):	Morell; Matthew (Australian Capital Territory, AU), Rahman; Sadequr (Melba, Australian Capital Territory, AU), Regina; Ahmed (Australian Capital Territory, AU)
Assignee:	Commonwealth Scientific and Industrial Research Organisation (Campbell, AU) Biogemma SAS (Paris, FR)
Application Number:	10/204,347
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,667,114
Patent Claims:	1. A wheat plant comprising a null allele of a gene on a long arm of chromosome 2 encoding wheat starch branching enzyme IIb (BEIIb), in combination with one or more null alleles of genes which encode starch branching enzyme IIa (BEIIa), granule bound starch synthase (GBSS), starch synthase II (SSII) or starch branching enzyme I (BEI). 2. The wheat plant of claim 1, wherein the gene encoding BEIIb is a wSBEII gene on a long arm of chromosome 2D. 3. The wheat plant of claim 1, wherein the gene encoding BEIIb corresponds to the partial BEIIb gene present on .lamda. phage clone G5, wherein a sample of G5 has been deposited with the Australian Government Analytical Laboratories under Accession No. NM01/19255. 4. The wheat plant of claim 2, wherein the wSBEII gene comprises introns of the following sizes: intron 1, 148 base pairs; intron 2, 663 base pairs; intron 3, 465 base pairs; intron 4, 74 base pairs; intron 5, 181 base pairs; intron 6, 442 base pairs; intron 7, 79 base pairs; and intron 8, 178 base pairs. 5. The wheat plant of claim 1, wherein the gene encoding BEIIb encodes an RNA corresponding to a cDNA having a nucleotide sequence as set forth in SEQ ID NO: 6. 6. The wheat plant of claim 1, further comprising a null allele of a second gene encoding BEIIb. 7. The wheat plant of claim 1, wherein the grain of the plant comprises an altered amylose-to-amylopectin ratio. 8. The wheat plant of claim 2, further comprising a null allele of a second gene encoding BEIIb. 9. The wheat plant of claim 1, comprising more than one null alleles of genes which encodes BEIIa.

Details for Patent 7,667,114

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2020-02-21
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2020-02-21
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2020-02-21